(RTTNews) - Pharmaceutical companies Mylan N.V. (MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced Thursday that the U.S. Food and Drug Administration (FDA) has approved Hulio ...
Biosimilars demonstrate comparable drug survival and safety with adalimumab among new users, but patients switching from Humira (the originator product) to biosimilars had a 35% higher discontinuation ...
Please provide your email address to receive an email when new articles are posted on . Only half of rheumatologists are “extremely comfortable” prescribing the Humira biosimilar Amjevita, while just ...
Hosted on MSN
Biocon Biologics secures full and exclusive global rights for Hulio (biosimilar adalimumab)
Mumbai, Dec. 23 -- Biocon Biologics, subsidiary of Biocon today announced that it has secured full and exclusive global rights for Hulio(R) (biosimilar Adalimumab) from Fujifilm Kyowa Kirin Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results